New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 7, 2014
12:10 EDTIBBishares Nasdaq Biotechnology Index heading for support test
A level to watch next week is the 30-day moving average. This has been a proxy for a hand-drawn uptrend line that is less noisy and therefore more close-fitting than the 10-day. The 30-day was last at $255.69. The 30-day hasn't been broken on the downside, for very long anyway, within the prior year. How price behaves at this test is therefore more important given the number of times it has held or preceded a consolidation (sideways) phase that then leads to greater highs.
News For IBB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 8, 2016
09:41 EDTIBBiShares Nasdaq Biotechnology Index is a new 52-week low
Subscribe for More Information
08:06 EDTIBBiShare Trust NASDAQ Biotech Index Fund volatility up into BIO Conference
Subscribe for More Information
February 5, 2016
15:10 EDTIBBiShares Nasdaq Biotechnology Index tests lows
Subscribe for More Information
February 3, 2016
09:54 EDTIBBiShares Nasdaq Biotechnology Index hits a new 52-week low
The ETF is down over 1.9% to $255.71, a new 52-week low. Support is at $248.94. Resistance is at $260.09.
January 28, 2016
10:53 EDTIBBiShare Trust NASDAQ Biotech Index Fund volatility increases on pullback
iShare Trust NASDAQ Biotech Index Fund January weekly call option implied volatility is at 65, February weekly is at 51, February is a 45; compared to its 52-week range of 23 to 53, suggesting large near term price movement.
10:25 EDTIBBiShares Nasdaq Biotechnology Index fall sharply, pulls indexes lower
The ETF was last at $261.02, down over 4.5% on the day. The negative effects of the underlying are helping to drag the broader indexes lower. Next support is at $256.92. Resistance is at $262.34.
January 26, 2016
09:57 EDTIBBiShares Nasdaq Biotechnology Index falls, levels to watch
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use